Some issues of sample size calculation for time-to-event endpoints using the Freedman and Schoenfeld formulas
This article deals with seven special issues related to the assumptions, applicability, and practical use of formulas for calculating power or sample size, respectively, for comparative clinical trials with time-to-event endpoints, with particular focus on the well-known Freedman and Schoenfeld meth...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
30 Jul 2015
|
| In: |
Journal of biopharmaceutical statistics
Year: 2015, Volume: 25, Issue: 6, Pages: 1285-1311 |
| ISSN: | 1520-5711 |
| DOI: | 10.1080/10543406.2014.1000546 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/10543406.2014.1000546
|
| Author Notes: | Ulrich R. Abel, Katrin Jensen, Irini Karapanagiotou-Schenkel & Meinhard Kieser |
| Summary: | This article deals with seven special issues related to the assumptions, applicability, and practical use of formulas for calculating power or sample size, respectively, for comparative clinical trials with time-to-event endpoints, with particular focus on the well-known Freedman and Schoenfeld methods. All problems addressed are illustrated by numerical examples, and recommendations are given on how to deal with them in the planning of clinical trials. |
|---|---|
| Item Description: | Gesehen am 18.11.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1520-5711 |
| DOI: | 10.1080/10543406.2014.1000546 |